Real-world evidence research in metastatic colorectal cancer: raising awareness of the need for patient contributions.

Real-world evidence (RWE) research helps determine whether outcomes observed in clinical trials happen in real-life clinical practice. RWE research may help patients receive more appropriate treatment, closer to their needs and wishes. RWE for metastatic colorectal cancer (mCRC) is currently limited. The PROMETCO RWE study is an important example of an ongoing initiative that focuses on patient-reported outcomes in mCRC. Patients play an active role throughout the RWE research process, including study design, participation and results dissemination. This involvement can encourage greater patient empowerment through active engagement, potentially resulting in various benefits that can lead to improved clinical outcomes. Greater patient engagement can increase involvement in RWE, helping more patients to access the benefits of RWE research.

[1]  Shi-peng Dai,et al.  Nomogram prediction of the role of metastasectomy in patients with colorectal cancer liver metastases: A SEER-Based competing risk analysis model. , 2022, Asian journal of surgery.

[2]  S. Ng,et al.  Prognosis of unresectable stage IV colon cancer with primary tumour resection. A multicenter study minimally or asymptomatic unresectable metastatic stage IV carcinoma of colon. , 2022, Asian journal of surgery.

[3]  B. Given,et al.  Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial. , 2022, JAMA.

[4]  E. Basch,et al.  The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  G. Bodoky,et al.  Rationale and design of the PROMETCO study: a real-world, prospective, longitudinal cohort on the continuum of care of metastatic colorectal cancer from a clinical and patient perspective. , 2022, Future oncology.

[6]  S. Lamb,et al.  Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation , 2021, BMJ.

[7]  D. Chodankar.  Introduction to real-world evidence studies , 2021, Perspectives in clinical research.

[8]  N. D. de Wit,et al.  Patients' preferred and perceived level of involvement in decision making for cancer treatment: A systematic review , 2021, Psycho-oncology.

[9]  R. Chilton,et al.  Real-world evidence and product development: Opportunities, challenges and risk mitigation , 2021, Wiener klinische Wochenschrift.

[10]  D. Schrag,et al.  Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. , 2021, JAMA.

[11]  B. Franklin,et al.  Exploring the theory, barriers and enablers for patient and public involvement across health, social care and patient safety: a systematic review of reviews , 2021, Health Research Policy and Systems.

[12]  H. Rumpold,et al.  Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis , 2020, BMC Cancer.

[13]  J. Borrás,et al.  A European survey on the insights of patients living with metastatic colorectal cancer: the patient journey before, during and after diagnosis - an Eastern European perspective , 2020, ESMO Open.

[14]  C. Punt,et al.  Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data , 2020, International journal of cancer.

[15]  A. Boivin,et al.  Partnering with patients in healthcare research: a scoping review of ethical issues, challenges, and recommendations for practice , 2020, BMC medical ethics.

[16]  J. Yost,et al.  Preparing for patient partnership: A scoping review of patient partner engagement and evaluation in research , 2020, Health expectations : an international journal of public participation in health care and health policy.

[17]  P. Buckhaults,et al.  Early-onset colorectal cancer: initial clues and current views , 2020, Nature Reviews Gastroenterology & Hepatology.

[18]  A. Batra,et al.  Role of real-world evidence in informing cancer care: lessons from colorectal cancer. , 2019, Current oncology.

[19]  A. Jemal,et al.  Global patterns and trends in colorectal cancer incidence in young adults , 2019, Gut.

[20]  W. Cheung,et al.  Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

[21]  V. Zadnik,et al.  Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years , 2019, Gut.

[22]  L. Forsythe,et al.  Patient Engagement In Research: Early Findings From The Patient-Centered Outcomes Research Institute. , 2019, Health affairs.

[23]  E. Perfetto,et al.  Patient-Community Perspectives on Real-World Evidence: Enhancing Engagement, Understanding, and Trust , 2019, The Patient - Patient-Centered Outcomes Research.

[24]  L. McDonald,et al.  Real-world data and the patient perspective: the PROmise of social media? , 2019, BMC Medicine.

[25]  Mark Conner,et al.  Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review , 2019, Journal of medical Internet research.

[26]  Kamlesh Khunti,et al.  Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician , 2018, Advances in Therapy.

[27]  P. Selby,et al.  Taking patient reported outcomes centre stage in cancer research – why has it taken so long? , 2018, Research Involvement and Engagement.

[28]  S. Oliver,et al.  How to incorporate patient and public perspectives into the design and conduct of research , 2018, F1000Research.

[29]  N. Roberts,et al.  Patient and public involvement in the design of clinical trials: An overview of systematic reviews , 2018, Journal of evaluation in clinical practice.

[30]  Robert White,et al.  Real world evidence (RWE) – a disruptive innovation or the quiet evolution of medical evidence generation? , 2018, F1000Research.

[31]  M. Boenink,et al.  The Benefits of Patient Involvement for Translational Research , 2017, Health Care Analysis.

[32]  M. Kris,et al.  Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment , 2017, JAMA.

[33]  G. Ehninger,et al.  Cancer patients’ control preferences in decision making and associations with patient-reported outcomes: a prospective study in an outpatient cancer center , 2017, Supportive Care in Cancer.

[34]  E. M. Castro,et al.  Patient empowerment, patient participation and patient-centeredness in hospital care: A concept analysis based on a literature review. , 2016, Patient education and counseling.

[35]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  D. Lavallee,et al.  Incorporating Patient-Reported Outcomes Into Health Care To Engage Patients And Enhance Care. , 2016, Health affairs.

[37]  C. Denlinger,et al.  Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed , 2015, Journal of personalized medicine.

[38]  X. Pivot,et al.  Endpoints in cancer clinical trials. , 2014, Journal of visceral surgery.

[39]  S. Vahdat,et al.  Patient Involvement in Health Care Decision Making: A Review , 2014, Iranian Red Crescent medical journal.

[40]  A. Regnault,et al.  Validation of Accept, a New Generic Measure to Assess How Patients with Chronic Diseases Balance Between the Advantages and Disadvantages of Following the Recommended Treatment Regimen in Real-life , 2013 .

[41]  S. Kaasa,et al.  Health care providers underestimate symptom intensities of cancer patients: A multicenter European study , 2010, Health and quality of life outcomes.

[42]  P. Sooriakumaran,et al.  The evolution of the doctor-patient relationship. , 2007, International journal of surgery.

[43]  Richard Thomson,et al.  The importance of patient preferences in treatment decisions—challenges for doctors , 2003, BMJ : British Medical Journal.

[44]  N. Houédé,et al.  Clinical Relevance of Routine Monitoring of Patient-reported Outcomes Versus Clinician-reported Outcomes in Oncology , 2018, In Vivo.

[45]  Shiraz I Mishra,et al.  Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. , 2006, Cancer detection and prevention.

[46]  R. Gray,et al.  A qualitative study of patient perspectives on colorectal cancer. , 2000, Cancer practice.

[47]  D. Nutbeam,et al.  Health promotion glossary (1998) , 1998 .